GlassScriptPhysician profile
Love Vimal
NPI 1255782603
$6,265.64
in general payments reported to CMS, 2019-2025
15 companies · $2,204 in 2025
The $2,204 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $13.45 · 2021: $1,710 · 2022: $480 · 2023: $1,289 · 2024: $135 · 2025: $2,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,532 · Food and Beverage: $1,080 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,531.89 |
| Food and Beverage | $1,079.62 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,907.66 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $2,164.26 | 2022-2025 | Phasix Mesh |
| Ethicon US, LLC | $291.34 | 2020-2021 | |
| Polarityte, INC. | $208.13 | 2019 | |
| Stryker Corporation | $147.15 | 2022 | |
| Becton, Dickinson and Company | $129.82 | 2019 | |
| Medtronic, INC. | $127.74 | 2021-2022 | |
| Rti Surgical, INC | $112.97 | 2023 | |
| Avanos Medical | $57.34 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.12 | 2021 | |
| Polynovo North America LLC | $22.53 | 2022 | |
| Innocoll Pharmaceuticals Limited | $20.62 | 2021 | |
| Integra Lifesciences Corporation | $18.36 | 2022 | |
| Apria Healthcare LLC | $16.71 | 2021 | |
| Coopersurgical, INC. | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Love Vimal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.